Advertisement

Topics

New Immunotherapy Candidate receives FDA Fast Track Designation

06:30 EST 21 Feb 2017 | Labiotech.eu

Cell Medica’s Orphan Drug CMD-003 has received fast track designation by the FDA to advance immunotherapy of  patients with Epstein Bar Virus (EBV)-associated malignancies. The FDA’s fast track designation has been designed to facilitate and accelerate the development of drugs which fill a ...

This awesome article New Immunotherapy Candidate receives FDA Fast Track Designation appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: New Immunotherapy Candidate receives FDA Fast Track Designation

NEXT ARTICLE

More From BioPortfolio on "New Immunotherapy Candidate receives FDA Fast Track Designation"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...